Vesicare

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Urinary Incontinence

Conditions

Urinary Incontinence

Trial Timeline

Oct 1, 2010 → May 1, 2013

About Vesicare

Vesicare is a pre-clinical stage product being developed by Astellas Pharma for Urinary Incontinence. The current trial status is completed. This product is registered under clinical trial identifier NCT01215721. Target conditions include Urinary Incontinence.

What happened to similar drugs?

20 of 20 similar drugs in Urinary Incontinence were approved

Approved (20) Terminated (1) Active (0)
Levofloxacin + LevofloxacinDr. Reddy's LaboratoriesApproved
SolifenacinAstellas PharmaApproved
Tamsulosin + SolifenacinAstellas PharmaApproved
Alpha blocker + placebo + solifenacinAstellas PharmaApproved
solifenacin succinate + PlaceboAstellas PharmaApproved

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT01215721Pre-clinicalCompleted
NCT01489709Pre-clinicalCompleted
NCT00581061Pre-clinicalTerminated

Competing Products

20 competing products in Urinary Incontinence

See all competitors